Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Medical Technology
  • IHealthScreen nabs FDA nod for AI-backed dx to spot mild diabetic retinopathy

IHealthScreen nabs FDA nod for AI-backed dx to spot mild diabetic retinopathy

July 10, 2026Posted inMedical Technology

IHealthScreen hauled in FDA 510(k) clearance for its AI-powered diagnostic that detects mild diabetic retinopathy in diabetic adults who have gone undiagnosed with the condition.

Post navigation

Previous Post
GSK sees phase 3 win for Hansoh-partnered ADC in China as validating its ‘priority asset’
Next Post
Genetic Mapping Reveals New Treatments for Bone Diseases genetic-mapping-reveals-new-treatments-for-bone-diseases

Recent Posts

  • Living Alone and Poverty Heighten Risks for Older Nigerians in Cities
  • YEARS Algorithm Enhances Pulmonary Embolism Diagnosis in Cancer Patients
  • Diverse Symptom Burdens and Care Needs in Older Ischemic Stroke Patients
  • KAIST Creates AI to Detect Early Cerebrovascular Disease Signs at Home
  • Anthropometric Traits and Metabolic Biomarkers Linked to Pancreatic Cancer Risk

Archives

  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • March 2024
  • January 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top